TacticScaleWhat Beijing Foyou Pharma (福元医药) Does & How It Makes Money (601089.SS)
Updated October 2026 · reflects Beijing Foyou Pharma's latest reported financials
Chinese maker of generic drugs, TCM and hospital medical devices. It earns revenue by manufacturing and selling pharmaceutical formulations, raw materials and medical devices to hospitals and other medical institutions and to retail pharmacies across China.
How Beijing Foyou Pharma makes money
It earns revenue by manufacturing and selling pharmaceutical formulations, raw materials and medical devices to hospitals and other medical institutions and to retail pharmacies across China.
What Beijing Foyou Pharma does
Beijing Foyou Pharma is a Beijing-based drugmaker, incorporated in 1999, that develops, manufactures and sells pharmaceutical formulations and medical devices in China. Its product range covers chemical drugs, traditional Chinese medicines and pharmaceutical raw materials. Its therapeutic areas include cardiovascular disease, chronic kidney disease, dermatology, digestive disorders, diabetes, neuropsychiatric conditions and gynecology. The company also has a medical device line made up mainly of hospital consumables and monitoring equipment. These include negative pressure drainage devices, digital urine collection bags, dynamic urine output monitors, disposable pressure sensors, urodynamic monitoring devices, nebulizers, and disposable oxygen masks and tubing. It sells through medical institutions and retail outlets, so its revenue comes from both hospital and pharmacy channels.
Products & services
- Chemical drug formulations
- Traditional Chinese medicines
- Pharmaceutical raw materials
- Digital urine collection bags and dynamic urine output monitors
- Negative pressure drainage devices
- Medical micro-mesh nebulizers and disposable oxygen masks
福元医药是做什么的？
北京福元医药股份有限公司成立于1999年，总部位于北京，主要在国内从事药品制剂和医疗器械的研发、生产与销售。产品包括化学药、中成药和原料药，覆盖心血管、慢性肾病、皮肤、消化、糖尿病、精神神经及妇科等治疗领域。 公司还经营医疗器械业务，产品以医用耗材和监测设备为主，包括负压引流装置、数字化集尿袋、动态尿量监测仪、一次性压力传感器、尿动力监测设备、鼻腔空气过滤器、医用微网雾化器、一次性雾化器、吸氧面罩和吸氧管等。产品通过医疗机构和零售终端销售，覆盖医院和药店两类渠道。
What is Beijing Foyou Pharma worth?
On an owner-earnings DCF, Beijing Foyou Pharma's most-likely value is about ¥8 versus a recent price near ¥16 (103% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥2) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ Capital-intensive — this business reinvests heavily, so free cash flow runs well below its earnings. Fair value here is built on free cash flow, which understates owner earnings for reinvestment-heavy companies — read it as conservative.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Shanghai Fosun Pharmaceutical (600196.SS) · Cofoe Medical Technology (301087.SZ) · Inner Mongolia Furui Medical Science (300049.SZ) · Sunflower Pharmaceutical (002737.SZ)